Review

The Korean Journal of Medicine 2008;75(1):312-312.

Phase 2 study of Low dose Leucovorin- modified FOLFIRI as first line therapy for patients with recurrent or metastatic gastric cancer (초)

Byung Geun Kim, Sung Yong Oh, Suee Lee, Dong Mee Lee, Jung Hwan Kim, Sung Hyun Kim, Hyuk Chan Kwon, Hyo Jin Kim

TOOLS

METRICS

Editorial Office: 101-2501, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea
Tel: +82-2-2271-6791 Fax: +82-2-790-0993 E-mail: kaim@kams.or.kr